Similarly, for CESC, Kaplan–Meier survival analysis also showed that the high expression of CDK6 led to poor prognosis for patients (HR = 1.24, p <.01), but the AUC at 1, 3, and 5 years was less than 0.7, indicating that the model of CDK6 expression used to predict clinical outcomes for patients in CESC has limitations. This evidence concerns the gene CDK6 and cervical squamous cell carcinoma.